Evidence map›Paper›PMID 34455198›Full record

ArticleInternational journal of hygiene and environmental health2021

HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - The HBM4EU survey.

Liese Gilles, Eva Govarts, Loïc Rambaud, Nina Vogel, Argelia Castaño, Marta Esteban López, Laura Rodriguez Martin, Gudrun Koppen, Sylvie Remy, Martine Vrijheid and 9 more

Abstract read
In one paragraph

Article in International journal of hygiene and environmental health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Liese GillesVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium. Electronic address: liese.gilles@vito.be.
Eva GovartsVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Loïc RambaudSanté Publique France, French Public Health Agency (ANSP), Saint-Maurice, France.
Nina VogelGerman Environment Agency (UBA), Berlin, Germany.
Argelia CastañoNational Center for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Marta Esteban LópezNational Center for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Laura Rodriguez MartinVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Gudrun KoppenVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Sylvie RemyVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Martine VrijheidBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Parisa MontazeriBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Laura BirksBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Ovnair SepaiPublic Health England, Chilton, United Kingdom.
Lorraine StewartPublic Health England, Chilton, United Kingdom.
Ulrike FiddickeGerman Environment Agency (UBA), Berlin, Germany.
Ilse LootsDepartment of Sociology (CRESC) and IMDO, University of Antwerp, Antwerp, Belgium.
Lisbeth E KnudsenDepartment of Public Health, University of Copenhagen, Denmark.
Marike Kolossa-GehringGerman Environment Agency (UBA), Berlin, Germany.
Greet SchoetersVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium; University of Southern Denmark, Institute of Public Health, Department of Environmental Medicine, Odense, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As part of the Human Biomonitoring for Europe (HBM4EU) initiative a human biomonitoring (HBM) survey is conducted in 21 countries. This survey builds on existing HBM capacity in Europe by aligning national or regional HBM studies. The survey targets 3 age groups (i) children aged 6-11 years, (ii) teenagers aged 12-19 years and (iii) young adults aged 20-39 years and includes a total of 9493 participants (3151 children, 2953 teenagers and 3389 young adults). Depending on the age group, internal exposure to phthalates and substitute Hexamoll® DINCH, brominated and organophosphorus flame retardants, per-/poly-fluorinated compounds, cadmium, bisphenols and/or polycyclic aromatic hydrocarbons are assessed. The main goal of the programme is to obtain quality controlled and comparable HBM data of exposure to chemicals, prioritized under HBM4EU, with European wide coverage to inform the development of environment and health policies. This paper describes the framework of the HBM4EU survey and the approach that has been applied to align European HBM initiatives across Europe.

Indexed as

Biological MonitoringCadmiumAdolescentChildEuropeHealth PolicyHumansSurveys and QuestionnairesYoung AdultCadmiumAdultsChildrenHuman biomonitoringJoint HBM4EU surveyTeenagers

Identifiers

PMID34455198
PMCPMC8504197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.